Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.
Since Nov 18, 2025
Transactions
20
Purchases
1
Sales
19
Purchase value
$1.40M
Sale value
$2.27M
Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.
John M LeonardDirector · President and CEO
4Rule 10b5-1 plan disclosed
Filed Nov 3, 2026Period of report Nov 2, 20260001193125-26-445417
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleNov 2, 2026
Common StockF1F2
9,000
$11.99
$107.91K
1,138,064
Direct
Filing footnotes · 3
F1The sales reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2026.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.65 to $12.60, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2026 at each separate price.
F3Shares held by the John M. Leonard 2015 Irrevocable Trust.
Filed Oct 6, 2026Period of report Oct 2, 20260001193125-26-415541
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleOct 2, 2026
Common StockF1
1,864
$12.43
$23.17K
65,022
Direct
Filing footnotes · 1
F1Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on October 1, 2026, and does not represent a volitional trade by the Reporting Person.
Filed Aug 24, 2026Period of report Aug 20, 20260001193125-26-363567
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleAug 21, 2026
Common StockF1
2,785
$13.00
$36.21K
1,147,064
Direct
SaleAug 20, 2026
Common StockF1F2
19,890
$12.60
$250.61K
1,149,849
Direct
Filing footnotes · 3
F1The sales reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2026.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.32 to $13.00, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 20, 2026 at each separate price.
F3Shares held by the John M. Leonard 2015 Irrevocable Trust.
Filed Jul 24, 2026Period of report Jul 22, 20260001193125-26-316279
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJul 22, 2026
Common StockF1F2
8,111
$11.25
$91.25K
148,175
Direct
Filing footnotes · 2
F1Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on July 22, 2026, and does not represent a volitional trade by the Reporting Person.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.25 to $11.28, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 22, 2026 at each separate price.
Filed Jul 6, 2026Period of report Jul 2, 20260001821530-26-000002
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJul 2, 2026
Common StockF1
4,677
$18.00
$84.19K
156,286
Direct
Filing footnotes · 1
F1The reported sale of 4,677 shares on this Form 4 occurred automatically pursuant to a 10b5-1 trading plan adopted by the reporting person on September 8, 2025.
Filed Jul 6, 2026Period of report Jul 1, 20260002019493-26-000002
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJul 1, 2026
Common StockF1F2
2,641
$16.78
$44.32K
66,886
Direct
Filing footnotes · 2
F1Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on July 1, 2026, and does not represent a volitional trade by the Reporting Person.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.78 to $17.12, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2026 at each separate price.
Filed Mar 3, 2026Period of report Mar 1, 20260001193125-26-088260
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 2, 2026
Common StockF2
1,211
$13.78
$16.69K
156,794
Direct
Filing footnotes · 3
F1Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit
F2Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on March 1, 2026, and does not represent a volitional trade by the Reporting Person.
F3This option was granted on March 1, 2026 with respect to shares of Common Stock, with 33% vesting on January 1, 2027 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.
Filed Mar 3, 2026Period of report Mar 1, 20260001193125-26-088241
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 2, 2026
Common StockF2
607
$13.78
$8.36K
93,864
Direct
Filing footnotes · 3
F1Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
F2Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on March 1, 2026, and does not represent a volitional trade by the Reporting Person.
F3This option was granted on March 1, 2026 with respect to shares of Common Stock, with 33% vesting on January 1, 2027 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.
Filed Jan 7, 2026Period of report Jan 5, 20260001193125-26-006294
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJan 5, 2026
Common StockF1
34,146
$9.21
$314.48K
1,013,339
Direct
Filing footnotes · 2
F1Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person.
F2Shares held by the John M. Leonard 2015 Irrevocable Trust.
Filed Jan 7, 2026Period of report Jan 5, 20260001193125-26-006292
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJan 5, 2026
Common StockF1F2
8,508
$9.21
$78.36K
98,533
Direct
Filing footnotes · 2
F1Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person.
F2Includes 925 and 932 shares acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2025 and December 31, 2025, respectively.
Filed Jan 7, 2026Period of report Jan 5, 20260001193125-26-006291
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJan 5, 2026
Common StockF1
10,397
$9.21
$95.76K
101,528
Direct
Filing footnotes · 1
F1Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person.
Filed Jan 7, 2026Period of report Jan 5, 20260001193125-26-006288
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
PurchaseJan 5, 2026
Common StockF1F2
150,000
$9.35
$1.40M
207,453
Direct
Filing footnotes · 2
F1Reflects an open market purchase of shares of the Issuer's common stock by the Reporting Person in accordance with the Issuer's trading policies.
F2The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.13 to $9.68, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares purchased by the reporting person on January 5, 2026 at each separate price.
Filed Jan 7, 2026Period of report Jan 5, 20260001193125-26-006283
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJan 5, 2026
Common StockF1F2
11,903
$9.21
$109.63K
121,249
Direct
Filing footnotes · 2
F1Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person.
F2Includes 1,022 and 1,264 shares acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2025 and December 31, 2025, respectively.
Filed Jan 7, 2026Period of report Jan 5, 20260001193125-26-006278
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJan 5, 2026
Common StockF1F2
9,515
$9.21
$87.63K
87,118
Direct
Filing footnotes · 2
F1Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person.
F2Includes 1,264 shares acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on December 31, 2025.
Filed Jan 7, 2026Period of report Jan 5, 20260001193125-26-006275
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJan 5, 2026
Common StockF1
6,379
$9.21
$58.75K
99,683
Direct
Filing footnotes · 1
F1Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person.
Filed Jan 7, 2026Period of report Jan 5, 20260001193125-26-006264
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJan 5, 2026
Common StockF1
2,989
$9.21
$27.53K
52,277
Direct
Filing footnotes · 1
F1Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person.
Filed Dec 12, 2025Period of report Dec 11, 20250001193125-25-317551
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleDec 11, 2025
Common StockF1F2
49,959
$9.49
$474.11K
1,077,115
Direct
SaleDec 11, 2025
Common StockF1F3
32,832
$9.47
$310.92K
1,044,283
Direct
SaleDec 11, 2025
Common StockF1F4
5,355
$9.59
$51.35K
1,038,928
Direct
Filing footnotes · 6
F1The sales reported on this Form 4 occurred automatically pursuant to a 10b5-1 trading plan adopted by the reporting person on September 11, 2025.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.33 to $9.64, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 11, 2025 at each separate price.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.30 to $9.57, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 11, 2025 at each separate price.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.57 to $9.65, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 11, 2025 at each separate price.
F5Shares held by the John M. Leonard 2015 Irrevocable Trust.
F6The stock option award was issued pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan and had vested in full as of December 11, 2025.
P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.